If you’re like pretty well everyone else, you’re closely watching Gilead Sciences (GILD), creator of remdesivir, a drug that, last week, showed progress in treating the coronavirus in a US government study. But does that make Gilead a good stock to buy now, particularly if you’re focused on income? Let’s take a look. First up, unlike many other stocks these days, Gilead boasts a safe payout, with the dividend accounting for just 38% of free cash flow in the last 12 months. And the company has increased its dividend every year since initiating it in 2015: A Reliable Dividend It’s on the current-yield front where the dividend story starts to fray.… Read more